KNSA.NASDAQKiniksa Pharmaceuticals International, PLC

Form 4: Kiniksa Pharmaceuticals Executive Reports Stock Transactions

Sentiment:

SEC Form 4 Filing

📋All filings for Kiniksa Pharmaceuticals International, PLC
🔒Login to Follow

Michael R. Megna, Chief Accounting Officer of Kiniksa Pharmaceuticals International, plc, reports the vesting and subsequent disposal of Class A Ordinary Shares to cover tax obligations.

Summary

  • On October 4, 2024, Michael R. Megna, Chief Accounting Officer of Kiniksa Pharmaceuticals International, plc, reported transactions involving Class A Ordinary Shares.
  • 175 shares were acquired through the vesting of Restricted Share Units (RSUs).
  • 82 shares were disposed of to satisfy tax withholding obligations at a price of $24.48 per share.
  • Following these transactions, Megna directly owns 26,528 Class A Ordinary Shares.
  • The reported transactions were filed pursuant to Section 16(a) of the Securities Exchange Act of 1934.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.

Industry Context

This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the transactions of company insiders.

Stakeholder Impact

  • The transactions have a minor impact on shareholders as they reflect routine executive compensation adjustments.

Key Dates

DateDescription
October 4, 2021Date of grant for the Restricted Share Units (RSUs) that vest over a four-year period.
October 4, 2024Date of the reported transactions: vesting of 175 RSUs and disposal of 82 shares for tax obligations.
October 8, 2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.